e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Pulmonary circulation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Assessment of atrial arrhythmogenic risk factors with body surface potential mapping in COPD patients
M. Sobieszczanska, M. Krasnowska, D. Kalka, A. Bielous-Wilk, R. Dobek, L. Rusiecki (Wrocaw, Poland)
Source:
Annual Congress 2005 - Pulmonary circulation
Session:
Pulmonary circulation
Session type:
Thematic Poster Session
Number:
2282
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Sobieszczanska, M. Krasnowska, D. Kalka, A. Bielous-Wilk, R. Dobek, L. Rusiecki (Wrocaw, Poland). Assessment of atrial arrhythmogenic risk factors with body surface potential mapping in COPD patients. Eur Respir J 2005; 26: Suppl. 49, 2282
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Risk factors for asymptomatic atrial fibrillation in patients with COPD
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018
Cardiac MRI right atrial area measurement thresholds for risk stratification in patients with PAH
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
Healthy smokers at risk for cardiovascular disease: the usefullness of left ventricular function and metabolic status evaluation.
Source: International Congress 2017 – Smoking and health hazards
Year: 2017
Evaluation of a new cardiac arrhythmias predictor in patients with COPD
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018
Is COPD a risk factor for electrocardiographic abnormalities and cardiac arrhythmias?
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016
Risk factors for new-onset atrial fibrillation in patients with asthma-COPD overlap syndrome (ACOS)
Source: International Congress 2019 – Insights into physiological diagnostic services
Year: 2019
Unexpected high prevalence of left ventricular cardiopathy in patients with COPD
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009
Epicardial fat mass is increased in patients with COPD: A non-invasive cardiovascular marker in a high risk population
Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life
Year: 2012
Novel method for assessment of the right ventricular contractile dysfunction in patients with severe COPD
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
Predictors for high ventricular arrhythmia burden in patients with heart failure with reduced ejection fraction and central sleep apnea: an analysis of the SERVE-HF major substudy
Source: Sleep and Breathing Conference 2021
Year: 2021
Atrial arrhythmias after lung transplantation: prevalence, risk factors, management and outcome
Source: International Congress 2018 – Epidemiology and prognostication of critically-ill patients
Year: 2018
Can BODE index identify right ventricular dysfunction in COPD patients?
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018
CT pulmonary angiography-derived right atrial area can risk stratify patients with PAH and PH
Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Year: 2019
Risk factors for the development of malignant arrhythmias in patients with obstructive sleep apnea and systolic ventricular dysfunction
Source: International Congress 2019 – Challenging issues in the clinical aspects of sleep-disordered breathing
Year: 2019
Assessment of left ventricular function in COPD
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
Reduced lung function and risk of atrial fibrillation in a prospective cohort study
Source: Eur Respir J 2002; 20: Suppl. 38, 401s
Year: 2002
High prevalence of altered cardiac repolarization in patients with COPD
Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Year: 2013
Prognostic value of right ventricular dilatation in patients with low risk pulmonary embolism
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017
Clinical and prognostic value of atrial natriutic peptide in patients with idiopathic pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 659s
Year: 2006
Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study
Source: Eur Respir J 2003; 21: 1012-1016
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept